Literature DB >> 11991991

Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6.

Hong Li1, John Nicholas.   

Abstract

Human herpesvirus 8-encoded interleukin-6 (vIL-6) signals through the gp130 signal transducer but is not dependent on the IL-6 receptor alpha subunit (IL-6R, gp80) that is required for signaling by endogenous IL-6 proteins; however, IL-6R can enhance vIL-6 activity and can enable signaling through a gp130 variant, gp130.PM5, that is itself unable to support vIL-6 signaling. These findings suggest that the vIL-6-gp130 interactions are qualitatively different from those of human IL-6 (hIL-6) and that vIL-6 signaling may be more promiscuous than that of hIL-6 but that IL-6R may play a role in vIL-6 signaling in vivo. To examine the receptor binding requirements of vIL-6, we have undertaken mutational analyses of regions of gp130 and IL-6R potentially involved in interactions with ligand or in functional complex formation and used these variants in functional, ligand-binding, and receptor dimerization assays. The data presented identify positions within two interstrand loops of the gp130 cytokine-receptor homology domain that are important for vIL-6 signaling and vIL-6-induced receptor dimerization and show that vIL-6, like hIL-6, can form complexes with IL-6R and gp130 but that the roles of putative cytokine-binding residues of IL-6R in ligand-induced functional complex formation are qualitatively different in the case of vIL-6 and hIL-6.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991991      PMCID: PMC137051          DOI: 10.1128/jvi.76.11.5627-5636.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.

Authors:  P S Moore; C Boshoff; R A Weiss; Y Chang
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

2.  Crystal structure of a cytokine-binding region of gp130.

Authors:  J Bravo; D Staunton; J K Heath; E Y Jones
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

3.  A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit.

Authors:  J Molden; Y Chang; Y You; P S Moore; M A Goldsmith
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

4.  Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6.

Authors:  J Nicholas; V R Ruvolo; W H Burns; G Sandford; X Wan; D Ciufo; S B Hendrickson; H G Guo; G S Hayward; M S Reitz
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

5.  Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex.

Authors:  U Horsten; G Müller-Newen; C Gerhartz; A Wollmer; J Wijdenes; P C Heinrich; J Grötzinger
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

Review 6.  Gp130 and the interleukin-6 family of cytokines.

Authors:  T Taga; T Kishimoto
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

7.  High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

Authors:  E Oksenhendler; G Carcelain; Y Aoki; E Boulanger; A Maillard; J P Clauvel; F Agbalika
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

8.  Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells.

Authors:  R Burger; F Neipel; B Fleckenstein; R Savino; G Ciliberto; J R Kalden; M Gramatzki
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

9.  Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells.

Authors:  H Asou; J W Said; R Yang; R Munker; D J Park; N Kamada; H P Koeffler
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

10.  Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction.

Authors:  M Kalai; F A Montero-Julian; J Grötzinger; V Fontaine; P Vandenbussche; R Deschuyteneer; A Wollmer; H Brailly; J Content
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

View more
  10 in total

Review 1.  Cytokine homologs of human gammaherpesviruses.

Authors:  Sang-Hoon Sin; Dirk P Dittmer
Journal:  J Interferon Cytokine Res       Date:  2011-12-05       Impact factor: 2.607

2.  Human herpesvirus 8-encoded cytokines.

Authors:  John Nicholas
Journal:  Future Virol       Date:  2010-03       Impact factor: 1.831

3.  Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6.

Authors:  Daming Chen; John Nicholas
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Genetic Analyses of Contributions of Viral Interleukin-6 Interactions and Signaling to Human Herpesvirus 8 Productive Replication.

Authors:  Qian Li; Qiwang Xiang; Daming Chen; John Nicholas
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

5.  Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6.

Authors:  Fang Hu; John Nicholas
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

6.  Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6.

Authors:  Daming Chen; Gordon Sandford; John Nicholas
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

7.  Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.

Authors:  Sandra Rebouissou; Mohamed Amessou; Gabrielle Couchy; Karine Poussin; Sandrine Imbeaud; Camilla Pilati; Tina Izard; Charles Balabaud; Paulette Bioulac-Sage; Jessica Zucman-Rossi
Journal:  Nature       Date:  2008-11-19       Impact factor: 49.962

8.  K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis.

Authors:  Jinshun Zhao; Vasu Punj; Hittu Matta; Lucia Mazzacurati; Sandra Schamus; Yanqiang Yang; Tianbing Yang; Yan Hong; Preethello M Chaudhary
Journal:  PLoS One       Date:  2007-10-24       Impact factor: 3.240

Review 9.  Multicentric Castleman disease and the evolution of the concept.

Authors:  Ting Zhou; Hao-Wei Wang; Stefania Pittaluga; Elaine S Jaffe
Journal:  Pathologica       Date:  2021-10

Review 10.  Structural biology of shared cytokine receptors.

Authors:  Xinquan Wang; Patrick Lupardus; Sherry L Laporte; K Christopher Garcia
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.